ProfileGDS4718 / 219866_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 99% 88% 98% 98% 87% 85% 99% 99% 98% 97% 99% 93% 92% 95% 92% 96% 94% 79% 77% 98% 98% 99% 98% 97% 94% 98% 92% 97% 90% 95% 90% 98% 99% 96% 77% 97% 98% 98% 71% 97% 87% 88% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.989897
GSM549102patient 115, normal, homogenized [OPG study]12.06699
GSM549104patient 119, normal, homogenized [OPG study]8.9750188
GSM549108patient 138, normal, homogenized [OPG study]11.550598
GSM549119patient 077, normal, homogenized [OPG study]11.941398
GSM549133patient 032, cancer, homogenized [OPG study]8.8354787
GSM549139patient 042, cancer, homogenized [OPG study]8.5524485
GSM549099patient 107, normal, homogenized [OPG study]11.897799
GSM549109patient 139, normal, homogenized [OPG study]12.137699
GSM549110patient 046, normal, homogenized [OPG study]11.75598
GSM549114patient 063, normal, homogenized [OPG study]11.377497
GSM549122patient 082, normal, homogenized [OPG study]12.282999
GSM549134patient 033, cancer, homogenized [OPG study]9.8138693
GSM549136patient 036, cancer, homogenized [OPG study]9.6026692
GSM549140patient 044, cancer, homogenized [OPG study]10.26795
GSM549111patient 047, normal, homogenized [OPG study]9.5755992
GSM549113patient 057, normal, homogenized [OPG study]10.791196
GSM549132patient 031, cancer, homogenized [OPG study]9.8256794
GSM549137patient 038, cancer, homogenized [OPG study]7.733979
GSM549142patient 047, cancer, homogenized [OPG study]7.328877
GSM549100patient 110, normal, homogenized [OPG study]11.540998
GSM549107patient 135, normal, homogenized [OPG study]11.598198
GSM549115patient 068, normal, homogenized [OPG study]12.177599
GSM549116patient 072, normal, homogenized [OPG study]11.363298
GSM549120patient 078, normal, homogenized [OPG study]11.143497
GSM549131patient 030, cancer, homogenized [OPG study]9.8913694
GSM549118patient 074, normal, homogenized [OPG study]11.442398
GSM549129patient 027, cancer, homogenized [OPG study]9.4499792
GSM549123patient 088, normal, homogenized [OPG study]11.058197
GSM549124patient 006, cancer, homogenized [OPG study]9.0871290
GSM549126patient 015, cancer, homogenized [OPG study]10.0595
GSM549128patient 025, cancer, homogenized [OPG study]9.2151190
GSM549103patient 117, normal, homogenized [OPG study]11.775598
GSM549117patient 073, normal, homogenized [OPG study]12.072399
GSM549138patient 041, cancer, homogenized [OPG study]10.405696
GSM549141patient 045, cancer, homogenized [OPG study]7.6669877
GSM549130patient 028, cancer, homogenized [OPG study]10.540297
GSM549101patient 111, normal, homogenized [OPG study]11.526398
GSM549105patient 128, normal, homogenized [OPG study]11.270498
GSM549106patient 134, normal, homogenized [OPG study]7.0434871
GSM549112patient 048, normal, homogenized [OPG study]11.006197
GSM549125patient 011, cancer, homogenized [OPG study]8.7285987
GSM549127patient 024, cancer, homogenized [OPG study]8.8599488
GSM549135patient 035, cancer, homogenized [OPG study]9.9183994